News
Prediction: These 3 Stocks Will Soar in 2024
No person knows for sure what the future will hold for stocks in the new year. However, it can be fun to attempt to predict what might happen.
Three Fool.com contributors have done just that. Here's
Why Coherus BioSciences Stock Jumped Today
Shares of Coherus BioSciences (NASDAQ: CHRS) are up 19.7% as of 3:20 p.m. ET Thursday after the U.S. Food and Drug Administration (FDA) approved Udenyca OnBody, the company's on-body injection
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
Small-cap stocks have been under pressure ever since the Federal Reserve started hiking interest rates in the first quarter of 2022. As a result, scores of companies in this category sport
Why Rocket Lab Stock Just Dropped 10%
Good news became bad news for Rocket Lab USA (NASDAQ: RKLB) on Friday after the company announced its successful return to launch operations for the first time since a mishap resulted in the
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?
Intellia Therapeutics (NASDAQ: NTLA) and CRISPR Therapeutics (NASDAQ: CRSP) have one big thing in common: They both specialize in the hot area of gene editing, or the repairing of faulty genes
EQS-News: Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP)
3 Unstoppable Stocks to Buy Right Now
What are some unstoppable stocks to buy right now? Three Fool.com contributors think they've found three stocks that qualify -- and they're all in the healthcare sector. Here's why they picked
Why Viking Therapeutics Was Crushing It This Week
A multibillion-dollar deal in the healthcare industry helped lift the stock of a company, Viking Therapeutics (NASDAQ: VKTX), not directly involved in the transaction. The deal centered around a hot
Is Novavax Stock a Buy Now?
Biotech company Novavax (NASDAQ: NVAX) went from being relatively unknown just four years ago to becoming one of the U.S. COVID-19 vaccine market leaders. The company has faced many trials and
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through
Why Abbvie Stock Popped Today
The big asset buy in the healthcare industry provided a healthy pop to the two companies involved on Thursday. The stock price of the buyer, sector mainstay AbbVie (NYSE: ABBV), enjoyed a nearly 3%
EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market
EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
You Don't Have to Pick a Winner in Biotech. Here's Why.
The biotech company that's able to deliver the next game-changing treatment might become tomorrow's winner -- and offer your portfolio a giant boost.
Problem is, it's not always easy to identify
EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
EQS-Adhoc: Termination of the botulinum toxin project
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?
Wall Street traders have numerous (and often creative) strategies to speculate on stocks and their up and down price movements. There are times when the prices of stocks are influenced more by what
CorMedix (CRMD) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)Q3 2023 Earnings CallNov 14, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Where Will Novavax Be in 3 Years?
A lot can happen in just a few years, and Novavax (NASDAQ: NVAX) is the proof of that. Three years ago, the company was rushing toward the coronavirus vaccine finish line -- and the shares were
Why Coherus BioSciences Was Plummeting This Week
A disappointing quarter combined with a set of analyst price target cuts -- and even a recommendation downgrade -- made Coherus BioSciences (NASDAQ: CHRS) a stock to avoid this week. As of
3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates
Last year, the Federal Reserve began hiking interest rates in an effort to slow down the economy. Today, interest rates are at their highest levels since the early 2000s. For many businesses, an
MannKind (MNKD) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q3 2023 Earnings CallNov 07, 2023, 5:00 p.m. ET
Operator
Source Fool.com
Why Coherus Biosciences Stock Dropped Today
Shares of Coherus Biosciences (NASDAQ: CHRS) were down by about 30% as of 3:25 p.m. ET Tuesday after the company announced disappointing third-quarter results and lowered its full-year guidance.
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Axsome Therapeutics (NASDAQ: AXSM)Q3 2023 Earnings CallNov 06, 2023, 8:00 a.m. ET
Operator
Source Fool.com